Titan Biotech Ltd — Results, 30-05-2025: Result

Titan Biotech has announced a board meeting to approve the financial results for the quarter and half-year ended March 31, 2025. The Board approved the audited standalone and consolidated financial results, with auditors issuing unmodified opinions. A dividend of Rs. 2 per equity share for FY 2024-25 has been proposed, subject to shareholder approval. The company appointed Mr. Amit Anand as Secretarial Auditor for five years, M/s Sanjay Kumar Garg & Associates as Cost Auditor for FY 2025-26, and PGM & Associates as Internal Auditor for two years from FY 2025-26. Mr. Pankaj Kumar Gupta has been appointed as the scrutinizer for the upcoming AGM voting process.